The pharma manufacturing chain is being upended by geopolitical uncertainties, changing regulations and manufacturing challenges, reducing the security and predictability that pharma needs to supply patients reliably. In this video roundtable, senior CDMO executives—including Adare's SVP of Sales & Marketing, Steven Facer—discuss how the industry can better partner with CDMOs to rethink supply chains of the future and to ensure more predictable cost-efficiency and access globally.
